Abstract
The use of azathioprine in ulcerative colitis is unclear. The authors present the details and outcome of 47 patients who received azathioprine for either a) severe, resistant disease otherwise requiring surgery (28 patients) or b) patients with steroid dependence who have been followed up for at least 12 months (19 patients). Duration of treatment ranged from one week to 66 months (median, 12 months). Of the patients in Group I, 13 (46 percent) achieved remission, 11 of whom had not relapsed during a median follow-up of 22 months (range, 12 to 58 months), and 15 underwent surgery one week to 12 months (median, five weeks) after commencing azathioprine. In Group II, steroids were withdrawn or reduced in 12 (63 percent) patients and three patients required colectomy. Side effects necessitating withdrawal of azathioprine occurred in 12 patients (hematologic effects, 6 patients; gastrointestinal effects, 4 patients; other effects, 2 patients). Two patients required a reduced dose of azathioprine because of leukopenia. The authors conclude that azathioprine is a valuable therapeutic option in selected patients with ulcerative colitis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bowen GE, Irons GV, Rhodes JB, Kirsner JB. Early experiences with azathioprine in ulcerative colitis. JAMA 1966;195:460–4.
Bean RH. Treatment of ulcerative collitis with antimetabolites. Br Med J 1966;1:1081–4.
Mackay IR, Wall AJ, Goldstein G. Response to azathioprine in ulcerative colitis. Am J Dig Dis 1966;11:536–45.
Mackay IR, Wall AJ. Letter to the editor. Am J Dig Dis 1968;13:850–1.
Theodor E, Gilon E, Waks U. Treatment of ulcerative colitis with azathioprine. Br Med J 1968;4:741–3.
Jones RA. Immunosuppressive therapy in ulcerative colitis. Proc R Soc Med 1969;62:499–501.
Patterson JF, Norton RA, Schwartz RS. Azathioprine treatment of ulcerative colitis, granulomatous colitis and regional enteritis. Dig Dis 1971;16:327–32.
Jewell DP, Truelove SC. Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. Br Med J 1974;4:627–30.
Rosenberg JL, Wall AJ, Levin B, Binder HJ, Kirsner JB. A controlled trial of azathioprine in the management of chronic ulcerative colitis. Gastroenterology 1975;69:96–9.
Kirk AP, Lennard-Jones JE. Controlled trial of azathioprine in chronic ulcerative colitis. Br Med J 1982;284:1291–2.
Burke DA, Dixon MF, Axon AT. Ulcerative colitis: prolonged remission following azathioprine-induced pancytopaenia. J Clin Gastroenterol 1989;11:327–30.
Theodor E, Niv Y, Bat L. Imuran in the treatment of ulcerative colitis. Am J Gastroenterol 1981;76:262–6.
Present DH, Chapman ML, Rubin PH. Efficacy of 6-mercaptopurine in refractory ulcerative colitis. Gastroenterology 1988;94:A359.
Lawson DH, Lovatt GE, Gurton CS, Hennings RC. Adverse effects of azathioprine. Adv Drug React Ac Pois Rev 1984;3:161–71.
Kinlen LJ, Sheil AG, Peto J, Doll R. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J 1979;2:1461–6.
MacLeod AM, Catto GR. Cancer after transplantation. Br Med J 1988;297:4–5.
Grunwald HW, Rosner F. Acute leukemia and immunosuppressive drug use. Arch Intern Med 1979;139:461–6.
Author information
Authors and Affiliations
About this article
Cite this article
Lobo, A.J., Foster, P.N., Burke, D.A. et al. The role of azathioprine in the management of ulcerative colitis. Dis Colon Rectum 33, 374–377 (1990). https://doi.org/10.1007/BF02156261
Issue Date:
DOI: https://doi.org/10.1007/BF02156261